FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968583845> ?p ?o ?g. }

• W2968583845 endingPage "e16813" @default.
• W2968583845 startingPage "e16813" @default.
• W2968583845 abstract "Abstract Dolutegravir (DTG) has shown effectiveness in combination with rilpivirine in with experience of antiretroviral therapy (ART) and with 3TC in naïve patients (GEMINI trial). The main objectives of this real-life study were to analyze the effectiveness and safety of 3TC plus DTG in virologically suppressed HIV-1 patients and to conduct a pharmacoeconomic analysis. We conducted an observational, retrospective and multicenter study of HIV+ patients pretreated for at least 6 months with ART that was then simplified to 3TC + DTG for any reason. We gathered data on viral loads (VLs) during exposure to the DT, calculating the rate with VL < 50 copies/mL at week 48, and on associated adverse effects. The 177 HIV+ patients were collected, 77.4% male, with average age of 48.5 years and mean count of 252.2cell/μL CD4+ nadir lymphocytes; 96.6% had VL < 50 copies/mL and 674 cells/μL CD4+ lymphocytes. Median time since HIV diagnosis was 15 years, and median ART duration was 13 years, and 34.5% of patients were on mono- or dual-therapy before the switch. At week 48, 82.4% of patients had VL < 50 cop/μL using an intention-to-treat (ITT) analysis, 89.6% according to mITT, and 96.7% according to Per-Protocol analysis. 3.3% patients had virological failure (VF). These effectiveness data and costs were compared with those for 2 reference triple therapies (DTG/ABC/3TC and EVG/cobi/FTC/TAF) in a cost minimization analysis, showing cost savings with administration of DTG+3TC (2741 €/year vs DTG/ABC/3TC and 4164 €/year vs EVG/cobi/FTC/TAF) and in a cost-effectiveness analysis, finding the DT to be the most cost-effective approach (ICER = −548 vs DTG/ABC/3TC and ICER = −4,627€ vs EVG/cobi/FTC/TAF) The combination of 3TC with DTG appears to be a safe and effective option for the simplification of ART in pretreated and virologically stable HIV-positive patients, being cost-effective and offering the same effectiveness as the triple therapy it replaces." @default.
• W2968583845 created "2019-08-22" @default.
• W2968583845 creator A5010232097 @default.
• W2968583845 creator A5019666393 @default.
• W2968583845 creator A5025610151 @default.
• W2968583845 creator A5028249068 @default.
• W2968583845 creator A5034884631 @default.
• W2968583845 creator A5036227932 @default.
• W2968583845 creator A5058087524 @default.
• W2968583845 creator A5060777472 @default.
• W2968583845 creator A5064082838 @default.
• W2968583845 creator A5072571178 @default.
• W2968583845 creator A5078511977 @default.
• W2968583845 creator A5088795886 @default.
• W2968583845 date "2019-08-01" @default.
• W2968583845 modified "2023-10-16" @default.
• W2968583845 title "DOLAMA study" @default.
• W2968583845 cites W1536774371 @default.
• W2968583845 cites W1544659534 @default.
• W2968583845 cites W2048142893 @default.
• W2968583845 cites W2115719856 @default.
• W2968583845 cites W2161992903 @default.
• W2968583845 cites W2196190612 @default.
• W2968583845 cites W2273406108 @default.
• W2968583845 cites W2595476392 @default.
• W2968583845 cites W2605932783 @default.
• W2968583845 cites W2606896492 @default.
• W2968583845 cites W2613086869 @default.
• W2968583845 cites W2728117782 @default.
• W2968583845 cites W2776856490 @default.
• W2968583845 cites W2781681713 @default.
• W2968583845 cites W2788591875 @default.
• W2968583845 cites W2791039963 @default.
• W2968583845 cites W2794989305 @default.
• W2968583845 cites W2805201313 @default.
• W2968583845 cites W2805477062 @default.
• W2968583845 cites W2899935160 @default.
• W2968583845 cites W2901677101 @default.
• W2968583845 cites W2911723209 @default.
• W2968583845 cites W2912203678 @default.
• W2968583845 doi "https://doi.org/10.1097/md.0000000000016813" @default.
• W2968583845 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6708975" @default.
• W2968583845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31393412" @default.
• W2968583845 hasPublicationYear "2019" @default.
• W2968583845 type Work @default.
• W2968583845 sameAs 2968583845 @default.
• W2968583845 citedByCount "36" @default.
• W2968583845 countsByYear W29685838452019 @default.
• W2968583845 countsByYear W29685838452020 @default.
• W2968583845 countsByYear W29685838452021 @default.
• W2968583845 countsByYear W29685838452022 @default.
• W2968583845 countsByYear W29685838452023 @default.
• W2968583845 crossrefType "journal-article" @default.
• W2968583845 hasAuthorship W2968583845A5010232097 @default.
• W2968583845 hasAuthorship W2968583845A5019666393 @default.
• W2968583845 hasAuthorship W2968583845A5025610151 @default.
• W2968583845 hasAuthorship W2968583845A5028249068 @default.
• W2968583845 hasAuthorship W2968583845A5034884631 @default.
• W2968583845 hasAuthorship W2968583845A5036227932 @default.
• W2968583845 hasAuthorship W2968583845A5058087524 @default.
• W2968583845 hasAuthorship W2968583845A5060777472 @default.
• W2968583845 hasAuthorship W2968583845A5064082838 @default.
• W2968583845 hasAuthorship W2968583845A5072571178 @default.
• W2968583845 hasAuthorship W2968583845A5078511977 @default.
• W2968583845 hasAuthorship W2968583845A5088795886 @default.
• W2968583845 hasBestOaLocation W29685838451 @default.
• W2968583845 hasConcept C126322002 @default.
• W2968583845 hasConcept C142462285 @default.
• W2968583845 hasConcept C159047783 @default.
• W2968583845 hasConcept C167135981 @default.
• W2968583845 hasConcept C197934379 @default.
• W2968583845 hasConcept C23131810 @default.
• W2968583845 hasConcept C2776623344 @default.
• W2968583845 hasConcept C2778723075 @default.
• W2968583845 hasConcept C2779502633 @default.
• W2968583845 hasConcept C2993143319 @default.
• W2968583845 hasConcept C3013748606 @default.
• W2968583845 hasConcept C71924100 @default.
• W2968583845 hasConceptScore W2968583845C126322002 @default.
• W2968583845 hasConceptScore W2968583845C142462285 @default.
• W2968583845 hasConceptScore W2968583845C159047783 @default.
• W2968583845 hasConceptScore W2968583845C167135981 @default.
• W2968583845 hasConceptScore W2968583845C197934379 @default.
• W2968583845 hasConceptScore W2968583845C23131810 @default.
• W2968583845 hasConceptScore W2968583845C2776623344 @default.
• W2968583845 hasConceptScore W2968583845C2778723075 @default.
• W2968583845 hasConceptScore W2968583845C2779502633 @default.
• W2968583845 hasConceptScore W2968583845C2993143319 @default.
• W2968583845 hasConceptScore W2968583845C3013748606 @default.
• W2968583845 hasConceptScore W2968583845C71924100 @default.
• W2968583845 hasIssue "32" @default.
• W2968583845 hasLocation W29685838451 @default.
• W2968583845 hasLocation W29685838452 @default.
• W2968583845 hasLocation W29685838453 @default.
• W2968583845 hasLocation W29685838454 @default.
• W2968583845 hasLocation W29685838455 @default.
• W2968583845 hasLocation W29685838456 @default.
• W2968583845 hasOpenAccess W2968583845 @default.

• next